Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.86 % |
3 Month Return | + 8.02 % |
1 Year Return | + 68.74 % |
Market Stats | |
Previous Close | ₹158.35 |
Open | ₹157.60 |
Volume | 2,113.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹181.87Cr |
P/E Ratio | 15.39 |
PEG Ratio | 10.26 |
Market Cap | ₹181.87 Cr |
P/B Ratio | 7.03 |
EPS | 8.38 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 6.54 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹181.87 Cr | 174.29% | 0.50 | ₹9 Cr | ₹188 Cr | |
BUY | ₹12,423.88 Cr | -3.8% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
NA | ₹1,067.07 Cr | -1.52% | 0.56 | ₹41 Cr | ₹338 Cr | |
NA | ₹561.76 Cr | 128.49% | 0.69 | -₹3 Cr | ₹111 Cr | |
NA | ₹3,528.84 Cr | 766.04% | 0.51 | NA | NA |
Organisation | Parnax Lab Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Parnax Lab Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, Parnax Lab stock has moved up by 56.4%
Best in 1 Year
In the last 1 year, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 19.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.30% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 27.70% of holdings in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 50.23 Cr → 49.31 Cr (in ₹), with an average decrease of 1.8% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 3.98 Cr → 3.41 Cr (in ₹), with an average decrease of 14.3% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.3% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 27.7% | 0.00 | |
Others | 0% | 0.00 |
Parnax Lab Ltd in the last 5 years
Lowest (-82.38x)
May 26, 2021
Today (15.39x)
January 21, 2025
Industry (55.69x)
January 21, 2025
Highest (177.62x)
February 9, 2021
Parnax Lab Ltd’s net profit jumped 82.35% since last year same period to ₹3.41Cr in the Q2 2024-2025. On a quarterly growth basis, Parnax Lab Ltd has generated -14.32% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Parnax Lab Ltd is currently in a Bearish trading position according to technical analysis indicators.
Parnax Lab Ltd share price today stands at ₹157.6, Open. ₹157.6 ; Previous Close. ₹158.35 ; High. ₹163.5 ; Low. ₹156.45 ; 52 Week High. ₹193.5 ; 52 Week Low: ₹81.
Parnax Lab Ltd is not listed on NSE
Parnax Lab Ltd is listed on BSE
PE Ratio of Parnax Lab Ltd is 15.39
PE ratio = Parnax Lab Ltd Market price per share / Parnax Lab Ltd Earnings per share
Today’s traded volume of Parnax Lab Ltd(506128) is 2,113.00.
Today’s market capitalisation of Parnax Lab Ltd(506128) is ₹181.87Cr.
Parnax Lab Ltd(506128 | Price |
---|---|
52 Week High | ₹193.5 |
52 Week Low | ₹81 |
Parnax Lab Ltd(506128) share price is ₹157.6. It is down -18.55% from its 52 Week High price of ₹193.5
Parnax Lab Ltd(506128) share price is ₹157.6. It is up 94.57% from its 52 Week Low price of ₹81
Parnax Lab Ltd(506128 | Returns |
---|---|
1 Day Returns | -0.75% |
1 Month Returns | -3.86% |
3 Month Returns | 8.02% |
1 Year Returns | 68.74% |